The new edition of the Atlas of MS is now available!
14 September 2020
Did you know that: 2.8 million people worldwide have multiple sclerosis (nearly 26,000 in Australia)? On average, a
Did you know that: 2.8 million people worldwide have multiple sclerosis (nearly 26,000 in Australia)? On average, a
Australian experts have teamed up with MS Research Australia to build an evidence-based lifestyle guide to help people living with MS.
The Pharmaceutical Benefits Advisory Committee (PBAC) has announced their recommendations for MS medications, siponimod (Mayzent) and ocrelizumab (Ocrevus).
MS research projects around Australia are set to receive a funding lifeline of $275,000 to complete research that risked non completion due to COVID-19.
MS Research Australia publishes the first Australian evidence-based guide on a variety of modifiable lifestyle factors to empower people with MS.
MS research study from world renowned researchers confirms that the risk of MS relapses reduces for women with MS during pregnancy.
Margaret is honoring her sister Helen’s memory by powering research through a gift in her Will.
Ozanimod has been approved by the TGA for the treatment of adults with relapsing forms of MS in Australia.
MS research in Australia received a major boost in funding, bringing the amount raised for life-changing MS research in 2020 to $10.5 million.